Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

3254 - Liver-type glutaminase (GAB) suppresses malignant phenotype of glioblastoma cells.

Date

11 Sep 2017

Session

Poster display session

Topics

Cancer Biology;  Central Nervous System Malignancies

Presenters

Ewelina Majewska

Citation

Annals of Oncology (2017) 28 (suppl_5): v595-v604. 10.1093/annonc/mdx391

Authors

E.J. Majewska1, M. Szeliga1, J. Márquez2, J. Albrecht1

Author affiliations

  • 1 Department Of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 - Warsaw/PL
  • 2 Department Of Molecular Biology And Biochemistry, Faculty of Sciences, Campus de Teatinos, University of Málaga, Malaga/ES
More

Resources

Abstract 3254

Background

Glutamine (Gln) plays a pivotal role in the metabolism of tumors of different including glioblastoma (GBM), the most aggressive brain tumor. Glutaminase (GA, EC 3.5.1.2) converts Gln to glutamate (Glu) and ammonia. GA is encoded by two genes: GLS and GLS2, encoding kidney-type isoforms (KGA and GAC) and liver-type isoforms (GAB and LGA), respectively. Kidney-type isoforms promote cell proliferation, while the liver-type isoforms relate to quiescent state of cells. In GBM GLS is highly expressed, while GLS2 is hardly detectable. Transfection of human GBM T98G cell line with a sequence encoding GAB is known to decrease their survival, proliferation index and migration and sensitizes them to damage by hydrogen peroxide. To examine whether the mode of action of GAB extends to other GBM cell lines, the effect of GAB transfection of U87MG, U251MG and LN229 cells with GAB was assessed.

Methods

Mitochondrial activity was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) conversion (details in M. Szeliga et al., Glia, 2009). Cell proliferation was measured by a commercially available ELISA kit based on the detection of BrdU (5-bromo-2'-deoxyuridine) incorporated into the genomic DNA. Migration was analyzed using the scratch assay. The tip scratch of cell monolayer was photographed under Juli Smart cell analyzer and measured after 0 and 24 h. Ability to form colonies was assessed after 14 days of culture following Giemsa staining of fixed cells.

Results

Transfection with GAB: i) decreased mitochondrial activity, proliferation and colony formation ability of U87MG cells ii) inhibited ability of U251MG cells to form colonies iii) decreased mitochondrial activity, proliferation, migration and colony formation ability of LN229 cells. All transfected cells were more sensitive to hydrogen peroxide as compared to the controls.

Conclusions

Suppression of malignant phenotype and their sensitization to hydrogen peroxide damage by GAB transfection appears to be a feature common to all the glioblastoma cell lines so far studied.

Clinical trial identification

Legal entity responsible for the study

Jan Albrecht, PhD

Funding

Ministry of Science and Higher Education of Poland, The Leading National Research Centre (KNOW-MMRC)

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.